Author(s)

L. A. Bockeria, A. A. Boldyrev, O. I. Kulaga, G. A. Blejyants, D. N. Egorov, A. E. Popov, K. V. Mumladze, I. F. Egorova, T. V. Artuhina, N. V. Kalaeva, R. R. Movsesian

Bakulev Scientific Center of Cardiovascular Surgery RAMS, Moscow, Russia.

Study objective involved comparison of two cardioplegic solutions: HTK-solution possessing high buffer capacity and a new ACH-solution with aminoacid buffer. Results revealed high cardioprotective efficiency during surgical repair of complex congenital heart disease both in the group that had received Custodiol and in the group that had received ACH-solution. Clinical and morphological parameters demonstrate high level of myocardial protection from intraoperative ischemia for single usage of ACH-solution during cardioplegic ischemia under 60 minutes in duration.

Cardioplegic Solution Natural Dipeptides; Cardioplegic Ischemia; Immature Myocardium

Bockeria, L. , Boldyrev, A. , Kulaga, O. , Blejyants, G. , Egorov, D. , Popov, A. , Mumladze, K. , Egorova, I. , Artuhina, T. , Kalaeva, N. and Movsesian, R. (2013) First Results of ACH Cardioplegic Solution Clinical Application in Newborns and Infants under One Year of Age. World Journal of Cardiovascular Diseases, 3, 33-39. doi: 10.4236/wjcd.2013.35A006.